Rick Dobrowsky receives NIH Innovation Grant

Congratulations to Dr. Rick Dobrowsky on receiving an NIH Innovation Grant to Nurture Initial Translational Efforts (IGNITE).

This grant will allow him to investigate the potential use of KU-596 as a treatment for the peripheral neuropathy associated with the inherited genetic disease, Charcot-Marie-Tooth 1X.